Barriers | Construct |
---|---|
Intervention characteristics | |
Formal training of HCWs | Knowledge, evidence strength |
Knowledge of government pharmaceutical procurement protocols and schedules | Complexity/access to knowledge and information |
Lab processing time, patients have to wait overnight at hospital for results | Complexity |
Outer setting | |
Transportation | Needs of community |
Time and money to get to clinics | Needs of community |
Education regarding TPT | Needs of community |
Increased pill burden | Needs of community/patients |
Not feeling sick, so why take medicine | Patient needs and resources |
Inner setting | |
Majority of community HCW’s are based in clinics and not in community | Readiness for implementation |
Stock outs of medication | Readiness for implementation |
Concerns around regimens, toxicity, and prescribing | Readiness for implementation/access to knowledge and information |
Ongoing debate/lack of consensus about IPT among healthcare providers | Readiness for implementation/relative priority |
Network/connectivity not always reliable at clinics, challenging to do online trainings, upload data, etc | Readiness for implementation/available resources |
Competing prioritization of TPT in clinics and hospitals | Priorities, culture |
Community stigma associated with TB and HIV | Compatibility |
Characteristics of individuals | |
Limited training of healthcare workers on clinical assessment, may contribute to missing cases | Knowledge and beliefs about the intervention |
Challenging access to the community because of poor roads and infrastructure | Complexity/readiness for implementation |
Communities are not taking DS-TB as seriously compared with HIV or DR-TB | Knowledge and beliefs about the intervention |
Flexibility in health provider’s visit/agenda with patients | Implementation climate/relative priority |
Fear of making a mistake or a misdiagnosis | Self-efficacy/knowledge of intervention |